Lorlatinib overcomes alectinib‐induced hemolytic anemia in an ALK fusion positive non‐small‐cell lung cancer patient with severe tumor‐associated liver failure: A case report... by Kei Kunimasa, Akito Miyazaki, Motohiro Tamiya, Takako Inoue, Takahisa Kawamura, Tsunehiro Tanaka, Shun Futamura, Kiyohide Komuta, Shigenori Nagata, Keiichiro Honma, Kazuyoshi Ohkawa, Kazumi Nishino

Get full text